Variant report
Variant | esv3324528 |
---|---|
Chromosome Location | chr6:34076874-34081272 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr6:34079999-34080142 | K562 | blood: | n/a | n/a |
2 | CTCF | chr6:34078196-34078253 | GM20000 | blood: | n/a | n/a |
3 | CTCF | chr6:34080000-34080150 | WERI-Rb-1 | eye: | n/a | n/a |
4 | CTCF | chr6:34080024-34080114 | Medullo | brain: | n/a | n/a |
5 | CTCF | chr6:34078447-34078492 | Pancreas_OC | pancreas: | n/a | n/a |
6 | CTCF | chr6:34080000-34080150 | BE2_C | brain: | n/a | n/a |
7 | RAD21 | chr6:34079828-34080250 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | RAD21 | chr6:34079948-34080269 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | RAD21 | chr6:34079924-34080216 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | ZNF263 | chr6:34081268-34081727 | HEK293-T-REx | kidney: | n/a | chr6:34081468-34081489 chr6:34081486-34081495 chr6:34081502-34081523 |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:34070510..34073396-chr6:34076306..34077910,2 | MCF-7 | breast: | |
2 | chr6:34080081..34083212-chr6:34095884..34099849,3 | MCF-7 | breast: | |
3 | chr6:34072071..34075419-chr6:34078119..34081173,3 | K562 | blood: | |
4 | chr6:34069851..34072638-chr6:34076441..34079307,2 | MCF-7 | breast: | |
5 | chr6:34070999..34073655-chr6:34074573..34077003,3 | K562 | blood: | |
6 | chr6:34080760..34083112-chr6:34091391..34094093,2 | K562 | blood: | |
7 | chr6:34065737..34070590-chr6:34071331..34077866,9 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GRM4 | TF binding region |
ENSG00000124493 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540354068 | chr6:34076882-34076883 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs114467678 | chr6:34076894-34076895 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs563318361 | chr6:34077000-34077001 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs140863900 | chr6:34077046-34077047 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs552157149 | chr6:34077084-34077085 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs571306898 | chr6:34077113-34077114 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs539882961 | chr6:34077192-34077193 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs538605629 | chr6:34077195-34077196 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs547376949 | chr6:34077209-34077210 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs566828527 | chr6:34077231-34077232 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs560295855 | chr6:34077243-34077244 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs536327085 | chr6:34077253-34077254 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs150172327 | chr6:34077264-34077265 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs560967390 | chr6:34077277-34077278 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs576527403 | chr6:34077290-34077291 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs537770407 | chr6:34077318-34077319 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs531192400 | chr6:34077377-34077378 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs180996335 | chr6:34077385-34077386 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs576918406 | chr6:34077442-34077443 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs77556944 | chr6:34077494-34077495 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs532533599 | chr6:34077541-34077542 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs574615868 | chr6:34077563-34077564 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs370691232 | chr6:34077582-34077583 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs145552542 | chr6:34077603-34077604 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs375587647 | chr6:34077711-34077712 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs571618390 | chr6:34077712-34077713 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs397807578 | chr6:34077717-34077718 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs530569813 | chr6:34077722-34077723 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs114538520 | chr6:34077775-34077776 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs564079949 | chr6:34077797-34077798 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs185664441 | chr6:34077807-34077808 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs533618287 | chr6:34077808-34077809 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs368435704 | chr6:34077822-34077823 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs552011164 | chr6:34077834-34077835 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs11966397 | chr6:34077844-34077845 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs565721281 | chr6:34077876-34077877 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs367562263 | chr6:34077936-34077937 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs548365388 | chr6:34077948-34077949 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs570236125 | chr6:34077968-34077969 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs537209122 | chr6:34077976-34077977 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs2087492 | chr6:34077978-34077979 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs535317376 | chr6:34077982-34077983 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs902205 | chr6:34077996-34077997 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs369524741 | chr6:34078009-34078010 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs145691081 | chr6:34078015-34078016 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs902206 | chr6:34078017-34078018 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs377042523 | chr6:34078028-34078029 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs902207 | chr6:34078080-34078081 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs902208 | chr6:34078084-34078085 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs5875490 | chr6:34078087-34078088 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:34025000-34101800 | Weak transcription | Right Atrium | heart |
2 | chr6:34051400-34089000 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr6:34067000-34097000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:34067200-34080600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:34067200-34089000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr6:34067400-34089000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr6:34068200-34078200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:34071600-34081800 | Weak transcription | Brain Anterior Caudate | brain |
9 | chr6:34076800-34077400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:34077200-34077400 | Bivalent Enhancer | Right Ventricle | heart |
11 | chr6:34077400-34080200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr6:34078200-34078800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr6:34078400-34078600 | Flanking Bivalent TSS/Enh | Foreskin Fibroblast Primary Cells skin02 | Skin |
14 | chr6:34078400-34079200 | Bivalent Enhancer | Fetal Brain Male | brain |
15 | chr6:34078400-34080800 | Enhancers | Fetal Brain Female | brain |
16 | chr6:34078600-34078800 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
17 | chr6:34078600-34078800 | Bivalent Enhancer | Stomach Smooth Muscle | stomach |
18 | chr6:34078800-34083600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr6:34079200-34080800 | Enhancers | Brain Germinal Matrix | brain |
20 | chr6:34079200-34080800 | Enhancers | Fetal Brain Male | brain |
21 | chr6:34079400-34079600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
22 | chr6:34079400-34079600 | Bivalent Enhancer | Fetal Stomach | stomach |
23 | chr6:34080200-34080800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
24 | chr6:34080600-34080800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
25 | chr6:34080800-34081600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
26 | chr6:34080800-34081800 | Weak transcription | Fetal Brain Female | brain |
27 | chr6:34080800-34082400 | Weak transcription | Fetal Brain Male | brain |
28 | chr6:34080800-34088200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |